How to Measure Your NAD+ Levels (Intracellular vs Blood)

Sophie Chabloz on July 30, 2026

How to Measure Your NAD+ Levels (Intracellular vs Blood)

By Sophie Chabloz | May 2026

If you're investing real money and time in NAD+ restoration, a baseline measurement lets you track whether it's working rather than just hoping it is. The question of how to measure NAD+ has more layers than most articles acknowledge. Different methods measure different things; some are clinically meaningful, some are noise. This piece sets out what's worth measuring, why intracellular NAD+ is more useful than circulating NAD+, and how the AVEA NAD+ Test Kit fits into a sensible testing protocol.

In this article:

  • The two compartments: blood (extracellular) and intracellular NAD+

  • Why intracellular matters more

  • The dried blood spot method

  • How to run a baseline-and-retest protocol

  • Interpreting your results

  • When testing isn't necessary

  • Where to go next

The two compartments: blood (extracellular) and intracellular NAD+

NAD+ exists in two pools in your body. Inside cells, where it does its work as a cofactor for sirtuins, PARPs, and oxidoreductases. And outside cells, in plasma and other extracellular fluids, where it serves a more limited signalling role.

Most early NAD+ research measured plasma NAD+ because plasma is easier to obtain and assay. Plasma NAD+ rises measurably after oral NMN dosing, and across NMN trials, plasma NAD+ elevation has been the most reproducible biomarker of supplement response.

But plasma NAD+ is a proxy. Cells don't run on extracellular NAD+. They run on the NAD+ they generate and maintain inside their own membranes. The relationship between plasma and intracellular NAD+ is correlated but not perfect, and the intracellular value is the one that matters for most of the outcomes you care about.

Why intracellular matters more

Three reasons intracellular NAD+ is the more meaningful measure.

First, all of NAD+'s primary functions happen inside cells. Mitochondrial energy production, sirtuin signalling, and PARP-mediated DNA repair all occur in the intracellular compartment. Plasma NAD+ doesn't directly support these processes.

Second, intracellular NAD+ reflects how well your salvage pathway is working. If your cells are taking up NMN efficiently and converting it to NAD+ via NMNAT, intracellular NAD+ will rise. If something in that conversion is impaired (low cellular uptake, an NMNAT bottleneck, methylation stress), intracellular NAD+ may not rise much even when plasma NAD+ does.

Third, intracellular NAD+ is the compartment that declines most steeply with age. The roughly 50 percent NAD+ decline between age 20 and 60 documented in tissue studies (Massudi et al., 2012) is an intracellular decline. Tracking the same compartment that's actually changing gives you a meaningful signal.

The technical challenge: intracellular NAD+ is harder to measure than plasma NAD+. You need access to actual cells. The dried blood spot method has emerged as the practical solution.

The dried blood spot method

Dried blood spot testing collects a small finger-prick blood sample on a specialised card. The sample is then processed by a laboratory using mass spectrometry to measure NAD+ inside red blood cells (erythrocytes), which serve as a stable proxy for intracellular NAD+ across the body.

The method has several practical advantages.

The collection is simple and can be done at home. You don't need a venipuncture or a clinical visit.

The samples are stable in transit. Dried blood spots can be mailed to the lab without temperature control.

The assay is reproducible. Modern mass spectrometry-based NAD+ measurement has tight precision and gives consistent results across batches.

The cost is reasonable. At-home dried blood spot tests are typically priced between 100 and 200 euros per measurement, depending on the provider.

The AVEA NAD+ Test Kit uses this dried blood spot method and reports your result against age-matched reference ranges, so you get both an absolute value and a sense of where you sit for your age.

How to run a baseline-and-retest protocol

For most users, a simple two-point measurement gives the most useful information.

Take a baseline measurement before starting your NMN protocol. This anchors your starting point and lets you interpret later results in context. The reading gives you both an absolute NAD+ value and a percentile relative to age-matched reference ranges.

Start your protocol. AVEA NMN at 250 mg or 500 mg per day is the typical starting dose. Lifestyle factors (sleep, alcohol, exercise) should be reasonably consistent during the test window so that NMN is the variable you're isolating.

Retest at 8 to 12 weeks. This is the window where intracellular NAD+ changes most fully consolidate. Earlier testing may underestimate the response; later testing doesn't add much for the initial assessment.

Compare. The increase from baseline to retest tells you whether your protocol is working as intended. In the AVEA internal case study, a 43-year-old man roughly doubled his intracellular NAD+ in three weeks on daily NMN, measured with AVEA's dried blood spot test. That kind of doubling is on the high end of typical responses; a 30-50 percent increase is more common at the 8-week mark.

Interpreting your results

Three patterns are most common.

NAD+ rose meaningfully (more than 30 percent above baseline). The protocol is working. Your absorption, dosing, and cellular conversion are all doing what they should. If you also feel better (energy, sleep, recovery), the biochemical and subjective signals are aligned. Continue.

NAD+ rose modestly (10-30 percent above baseline). Partial response. Common explanations: the dose may be too low for your situation, lifestyle factors may be working against you, or the response is genuinely real but smaller than expected for your individual physiology. Consider stepping up the dose (250 mg to 500 mg, or 500 mg to 750 mg) or addressing surrounding factors before retesting.

NAD+ didn't rise meaningfully (less than 10 percent change). Something is failing. The most common explanation is product quality. The 2021 ConsumerLab analysis found more than half of NMN sold online contained essentially zero NMN. If you're using a brand without third-party verification, that's the likely culprit. Switch to a verified product (AVEA NMN uses Longevir, with batch-level Swiss lab testing) and retest. If a quality NMN still doesn't move your levels, the issue may be cellular conversion or methylation, and a clinical workup is appropriate.

When testing isn't necessary

Testing isn't required for everyone.

If you're young (under 40) and metabolically healthy, the NAD+ deficit you're trying to address is modest. The cost of testing may exceed its informational value. You can take a quality NMN as preventive insurance and rely on subjective response (energy, sleep) as your primary feedback.

If you're cost-constrained, the money is better spent on a quality NMN supplement than on testing a poor one. Test when you're confident you're using a verified product and want to confirm the response.

If you respond clearly to NMN within the first month (energy, focus, and sleep all improving as expected), the protocol is working and additional testing is confirmatory rather than essential.

For users in their 40s, 50s, and beyond, especially those starting a serious longevity protocol or troubleshooting a non-response, testing earns its cost by giving you a hard number instead of a guess.

Where to go next

If you want to know what timeline to expect when you start NMN, "How long does NMN take to raise NAD+ levels" covers the response curve. To compare your test results with other measures of biological ageing, "Biological age testing: epigenetic clocks compared" covers the broader testing landscape. And "NAD+ Decline and How to Restore It" brings everything together.

Related reading from AVEA insights